Artal Group’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$56.3M Buy
2024
Q1
$77.3M Sell
2023
Q4
$85.1M Sell
2023
Q3
$63.3M Buy
2023
Q2
$95.7M Sell
2023
Q1
$80.2M Buy
2022
Q4
$46.5M Sell
2022
Q3
$68.3M Buy
2022
Q2
Sell
2022
Q1
$10.2M Buy
2019
Q2
Sell
2019
Q1
$5.85M Buy